CATALENT - BLOW-FILL-SEAL STERILE CONTRACT DEVELOPMENT AND MANUFACTURING BUSINESS
Blow-Fill-Seal Sterile CDMO Business is focusing on complex clinical to commercial-stage formulation and manufacturing. The Business supports a global, blue-chip customer base with a broad array of products that leverage its BFS sterile manufacturing capabilities and formulation competency in complex chemistries including small molecule, biologics, macromolecules, and potent compounds.
CATALENT - BLOW-FILL-SEAL STERILE CONTRACT DEVELOPMENT AND MANUFACTURING BUSINESS
Industry:
Biotechnology Health Care Manufacturing Pharmaceutical
Address:
Somerset, New Jersey, United States
Country:
United States
Status:
Active
Similar Organizations
GJ Chemical Co. Inc
GJ Chemical Co. Inc is a chemical company that provides pharmaceutical and industrial acids.
Pharmaceutical Processing
Pharmaceutical Processing is the leading source of pharmaceutical and biopharmaceutical manufacturing news.
More informations about "Catalent - Blow-Fill-Seal Sterile Contract Development and Manufacturing Business"
SK Capital Announces Agreement to Acquire Catalent’s Blow-Fill …
New York, January 6, 2021 – SK Capital Partners LP, a private investment firm focused on the specialty materials, chemicals and pharmaceuticals sectors, today announced that funds it …See details»
Catalent Divests Blow-Fill-Seal Sterile CDMO Business
Jan 7, 2021 SK Capital Partners, a private investment firm focused on the specialty materials, chemicals and pharmaceuticals sectors, has acquired the Blow-Fill-Seal (BFS) sterile contract …See details»
SK Capital Closes Acquisition of Catalent’s Blow-Fill-Seal Sterile …
New York, March 31, 2021 – Funds managed by SK Capital Partners LP, a private investment firm focused on the specialty materials, chemicals and pharmaceuticals sectors, completed the …See details»
SK Capital Announces Agreement to Acquire Catalent’s Blow-Fill …
Advises have signed a definitive agreement to acquire the Blow-Fill-Seal (“BFS”) Sterile Contract Development and Manufacturing Business (the “Business”) from Catalent Pharma Solutions, …See details»
After its breakout from Catalent, Woodstock Sterile Solutions …
Jul 6, 2021 It’s not quite as illustrious, but its main resident, Woodstock Sterile Solutions, wants to make it an elite address in the blow-fill-seal business. The BFS manufacturing approach is a …See details»
Deal for Catalent’s blow-fill-seal business now official
Apr 1, 2021 SK Capital Partners LP, a private investment firm that focuses on the specialty materials, chemicals and pharmaceuticals sectors, has formally completed the previously …See details»
Catalent inks deal to offload blow-fill-seal business to …
Jan 6, 2021 Private equity firm SK Capital is ponying up an undisclosed sum to purchase Catalent’s blow-fill-seal sterile CDMO business. With a definitive agreement locked down, the parties expect the deal ...See details»
SK Capital Closes Acquisition of Catalent’s Blow-Fill …
Mar 31, 2021 SK Capital Acquires Catalent’s Blow-Fill-Seal Sterile CDMO Business, Changes Name to Woodstock Sterile Solutions; Announces CEO Paul Josephs Contacts Jeremy Milner BackBay Communications 401-862 ...See details»
Catalent - Crunchbase Company Profile & Funding
Blow-Fill-Seal Sterile CDMO Business is focusing on complex clinical to commercial-stage formulation and manufacturing. The Business supports a global, blue-chip customer base with a broad array of products that leverage …See details»
SK Capital Announces Agreement to Acquire Catalent’s Blow-Fill …
Jan 6, 2021 The Business is a leading BFS sterile contract development and manufacturing organization (CDMO) that operates out of a single site in Woodstock, Illinois, focusing on …See details»
Catalent sells blow-fill-seal unit | Pharma Manufacturing
Jan 7, 2021 Catalent, one of the contract manufacturers playing a leading role in coronavirus vaccine production, has struck a deal to offload one of its business units. This week, the …See details»
SK Capital Closes Acquisition of Catalent’s Blow- Fill-Seal Sterile ...
The previously announced acquisition of the Blow-Fill-Seal (“BFS”) Sterile Contract Development and Manufacturing business from Catalent Pharma Solutions, LLC. The business has been …See details»
Catalent - Blow-Fill-Seal Sterile Contract Development and ...
Jul 6, 2021 Catalent (NYSE:CTLT) provides advanced delivery technologies and development solutions for drugs, biologics, and consumer health products. Use the CB Insights Platform to …See details»
SK Capital Completes Acquisition of Catalent’s Blow-Fill-Seal CDMO
Apr 1, 2021 SK Capital Partners, a private investment firm focused on the specialty materials, chemicals, and pharmaceuticals sectors, announced on March 31, 2021 it has completed its …See details»
SK Capital Announces Agreement to Acquire Catalent’s Blow-Fill …
Jan 6, 2021 NEW YORK--(BUSINESS WIRE)-- SK Capital Partners LP, a private investment firm focused on the specialty materials, chemicals and pharmaceuticals sectors, today …See details»
SK Capital Announces Agreement to Acquire Catalent’s Blow-Fill …
Jan 6, 2021 SK Capital Partners LP, a private investment firm focused on the specialty materials, chemicals and pharmaceuticals sectors, today announced that funds it advises have …See details»
How Catalent Pulled Off a Megadeal With Threats Looming in …
1 day ago We also had to educate regulators about what a contract development and manufacturing organization like Catalent actually does. Many agencies didn’t fully grasp the …See details»
SK Capital Closes Acquisition of Catalent’s Blow-Fill-Seal Sterile …
New York, March 31, 2021 – Funds managed by SK Capital Partners LP, a private investment firm focused on the specialty materials, chemicals and pharmaceuticals sectors, completed the …See details»
SK Capital Announces Agreement to Acquire Catalent’s Blow-Fill …
Jan 15, 2021 SK Capital Partners LP, a private investment firm focused on the specialty materials, chemicals and pharmaceuticals sectors, today announced that funds it advises have …See details»
Global manufacturing continues its tradition in Woodstock
New York, March 31, 2021 – Funds managed by SK Capital Partners LP, a private investment firm focused on the specialty materials, chemicals and pharmaceuticals sectors, completed the …See details»